In this edition:
Follow-up pelvic examinations after adjuvant radiation for endometrial cancer
PARPi resistance in high-grade serous ovarian cancer
Long-term survival in high-grade serous ovarian cancer
BEACON: bevacizumab-atezolizumab-cobimetinib in platinum-resistant, high-grade serous ovarian cancer
PORTEC-3: 10-year update
Racial disparities in clinical trials
ICON-9: olaparib + cediranib at first relapse in platinum-sensitive ovarian cancer
Barcode clonal tracking in mucinous ovarian cancer
The CDCP1 receptor as a target for imaging/treatment of ovarian cancer
HRD testing in ovarian cancer ascites
Please login below to download this issue (PDF)